1. IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT. (21st September 2021) Authors: Finocchiaro, Gaetano; Eoli, Marica; Gentner, Bernhard; Capotondo, Alessia; Anghileri, Elena; Antonarelli, Gabriele; Barcella, Matteo; Bruzzone, Maria Grazia; Carrabba, Matteo; Cuccarini, Valeria; D'Alessandris, Quintino G; DiMeco, Francesco; Farina, Francesca; Ferla, Valeria; Ferroli, Paolo; Gagl... Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗